Antibodies, nanobodies, or aptamers—which is best for deciphering the proteomes of non-model species?

26Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

This planet is home to countless species, some more well-known than the others. While we have developed many techniques to be able to interrogate some of the “omics”, proteomics is becoming recognized as a very important part of the puzzle, given how important the protein is as a functional part of the cell. Within human health, the proteome is fairly well-established, with numerous reagents being available to decipher cellular pathways. Recent research advancements have assisted in characterizing the proteomes of some model (non-human) species, however, in many other species, we are only just touching the surface. This review considers three main reagent classes—antibodies, aptamers, and nanobodies—as a means of continuing to investigate the proteomes of non-model species without the complications of understanding the full protein signature of a species. Considerations of ease of production, potential applications, and the necessity for producing a new reagent depending on homology are presented.

Cite

CITATION STYLE

APA

Dhar, P., Samarasinghe, R. M., & Shigdar, S. (2020, April 1). Antibodies, nanobodies, or aptamers—which is best for deciphering the proteomes of non-model species? International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21072485

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free